Mouse Castration Preprint Reports Longer Survival Without Slower Physical Decline

On October 24, 2026, Laurence T. Maeyens and colleagues posted “Beneficial early, harmful later: age-dependent effects of testicular factors on male mortality” on bioRxiv.

What was the main finding?

The authors reported longer median lifespans in all intervention groups: 19.3% after castration at 20 days and 25.8% after castration at 60 days. The largest reported increase was 32.9% in mice castrated at 240 days, which the preprint places just before the typical rise in male mortality. Yet Science reported that grip strength and other signs of physical decline worsened at similar rates across the castrated groups. The central finding is therefore a survival advantage alongside continuing physical decline, a combination that makes the choice of aging outcome important.

Which animals were studied, and how were outcomes assessed?

Animal model: The study was conducted in male UM-HET3 mice, not humans or cell cultures.

The study used male UM-HET3 mice, which the authors describe as genetically heterogeneous. Researchers performed castration at 20 days, 60 days or 240 days and compared survival with controls. Science identifies those controls as mock-operated animals. This design makes intervention timing a central comparison rather than treating castration as a single exposure with a single lifespan result.

According to Science, every castrated group outlived the mock-operated controls. The ordering of the reported median gains is especially interesting: the latest intervention produced the largest increase. That pattern shifts attention from whether reproductive biology affects survival to how the age at intervention might shape the outcome.

Median lifespan marks the middle of a group's survival distribution, rather than the longest life recorded. A higher median therefore describes a group-level result. It does not mean that every mouse received the same additional lifespan. That distinction is useful when reading other mouse lifespan reports and deciding what their headline numbers represent.

The preprint builds on earlier work by the same group, which it describes as finding that castration before puberty allowed male UM-HET3 mice to live about as long as females. The new experiment changes the timing question. Instead of focusing only on a prepubertal intervention, it includes an intervention performed in adulthood.

Science also reports that no mouse in the adult-castrated group died for more than a year after the procedure. The authors describe the 240-day intervention as preventing the early excess mortality seen in males. Those observations focus attention on the timing of deaths, not just the final summary percentage.

Survival was not the only outcome that changed. The preprint reports a shift toward what the authors call a female-like body composition, with less lean mass and continued fat accumulation later in life. That description identifies the direction of a biological change. It should not be read as a general ranking of one body composition as healthier than another.

Why might testicular factors affect survival differently with age?

The authors' proposed explanation is that testicular factors have different effects at different ages. In their interpretation, those factors may be beneficial earlier in life but harmful to survival later. The study title captures that proposed reversal. Its scientific interest lies in the possibility that the same biological system could contribute differently to mortality as an animal ages.

One reason the adult intervention matters is that an effect emerging after castration in adulthood poses a different research question from an effect seen only after early-life surgery. A proposed explanation has to account for the timing pattern, rather than simply noting that castrated mice lived longer. The largest reported gain did not require the earliest intervention.

That is also why the mismatch between survival and physical function deserves attention. If a proposed explanation focuses on broadly preserving physical condition, it needs to fit the measurements Science describes. A useful hypothesis should explain the observed combination of outcomes, rather than replace them with a general claim of slower aging.

Experts quoted by Science separate enthusiasm for the survival result from confidence in the proposed explanation. Michael Garratt said he was convinced that late-life castration caused a robust increase in survival. Steve Austad called the age-dependent interpretation a “provocative hypothesis” needing more evidence. Those assessments address different parts of the same study.

Biogerontologist Ashley Webb, who was not involved in the study, called it “an important step” toward understanding sex differences in lifespan. Her assessment highlights the value of the experiment as a way to ask sharper biological questions.

The broader question is relevant to sex differences in longevity. Science notes that women outlive men across many populations and quotes Austad describing the female longevity advantage as one of the most robust features of human biology. That background explains why researchers are interested in reproductive biology as a source of testable questions about survival.

Science reports that researchers hope to identify the relevant testicular factors and investigate a nonsurgical “castration mimetic.” This is a research idea for reproducing a biological effect, not an existing treatment. Keeping survival evidence separate from broader aging claims helps preserve the distinction between identifying a promising question and having an intervention ready to use.

What are the main limitations?

• The report is not peer reviewed. The work was posted as a bioRxiv preprint rather than a peer-reviewed journal article. The reported survival gains should be evaluated with that publication status in mind. The practical reading rule is to keep the preprint status attached to the result when discussing it, rather than allowing the size of the reported effect to substitute for evaluation of the study.
• Group size and statistical detail are absent from the accessible summaries. Science does not provide the sample size, and the accessible preprint excerpt does not give animals per group or detailed statistical methods. This limits an independent assessment of precision from those accounts. A fuller evaluation needs the underlying methods and group-level results, not an assumed animal count or an invented estimate of uncertainty.
• The intervention does not isolate testosterone. Garratt cautioned in Science that castration causes many biological changes. It is therefore premature to attribute the survival pattern to testosterone alone. The relevant research task is to identify which changes contribute to the outcome and test them directly, rather than treating removal of the testes as a precise experiment on a single hormone.
• The evidence remains specific to this mouse experiment. Neither the reported median gains nor the intervention ages provide a prediction for people. The study does not support pursuing castration or changing hormone treatment for longevity. For readers considering a personal hormone-related decision, the appropriate route is qualified clinical care rather than using this preprint as a treatment guide.

What should researchers test next?

The next step is to reproduce the age-dependent survival pattern in male mice and test specific testicular factors while measuring both causes of death and physical function.

How AgeAmaze helps

A longer mouse lifespan can sound like a human opportunity before the biology has been explained; AgeAmaze makes that interpretive leap explicit instead of presenting it as a conclusion. For readers sorting animal experiments from evidence in people, its research-led articles explain aging mechanisms and study limits so that an intriguing result remains distinct from an established intervention.

Read the research

Sources

1. Castration extends life span, but in a surprising way, mouse ...
2. Beneficial early, harmful later: age-dependent effects of testicular factors on male mortality